Biocon Biologics gets MHRA approval for YESAFILI, biosimilar Aflibercept EP News Bureau Nov 13, 2023 In September, YESAFILI received marketing authorisation approval from the European Commission (EC) for the European Union (EU)
Biocon Biologics gets EC approval for YESAFILI, biosimilar Aflibercept EP News Bureau Sep 20, 2023 The EC decision follows the European Medicines Agency’s CHMP positive opinion recommending approval of YESAFILI in July
